Codexis, Inc.

CDXS

$2.65

Name : Codexis, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $238,757,440.00

EPSttm : -0.8

Codexis, Inc.

$2.65

3.32%

$0.085

Float Short %

6.44

Margin Of Safety %

Put/Call OI Ratio

0.13

EPS Next Q Diff

0.06

EPS Last/This Y

0.29

EPS This/Next Y

-0.02

Price

2.65

Target Price

7.08

Analyst Recom

1.57

Performance Q

-14.95

Relative Volume

0.33

Beta

2.58

Ticker: CDXS

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	CDXS	2.45	0.09	0.13	2731
2025-09-09	CDXS	2.45	0.09	0.20	2736
2025-09-10	CDXS	2.43	0.10	0.00	2804
2025-09-11	CDXS	2.44	0.10	0.00	2780
2025-09-12	CDXS	2.43	0.10	0.00	2778
2025-09-15	CDXS	2.45	0.10	20.40	2780
2025-09-16	CDXS	2.49	0.10	0.00	2782
2025-09-17	CDXS	2.35	0.10293526336952	0	2743
2025-09-18	CDXS	2.48	0.10	0.10	2742
2025-09-22	CDXS	2.51	0.11	0.00	2373
2025-09-23	CDXS	2.45	0.11	0.00	2405
2025-09-24	CDXS	2.48	0.11	0.00	2432
2025-09-25	CDXS	2.4	0.11	0.00	2437
2025-09-26	CDXS	2.45	0.11	0.50	2453
2025-09-29	CDXS	2.47	0.11	0.50	2454
2025-09-30	CDXS	2.43	0.11	0.00	2454
2025-10-01	CDXS	2.51	0.11	0.84	2461
2025-10-02	CDXS	2.52	0.11	0.10	2477
2025-10-03	CDXS	2.54	0.11	0.61	2499
2025-10-06	CDXS	2.68	0.12	0.00	2524
2025-10-07	CDXS	2.56	0.12	0.21	2512
2025-10-08	CDXS	2.65	0.13	0.00	2566
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	CDXS	2.45	56.3	-	-0.60
2025-09-09	CDXS	2.45	56.3	-	-0.60
2025-09-10	CDXS	2.43	56.3	-	-0.60
2025-09-11	CDXS	2.44	56.3	-	-0.60
2025-09-12	CDXS	2.43	56.3	-	-0.60
2025-09-15	CDXS	2.45	56.3	-	-0.60
2025-09-16	CDXS	2.49	56.3	-	-0.60
2025-09-17	CDXS	2.34	56.3	-	-0.60
2025-09-18	CDXS	2.49	56.3	-	-0.60
2025-09-19	CDXS	2.43	56.3	-	-0.60
2025-09-22	CDXS	2.52	56.3	-	-0.60
2025-09-23	CDXS	2.45	56.3	-	-0.60
2025-09-24	CDXS	2.49	56.3	-	-0.60
2025-09-25	CDXS	2.40	56.3	-	-0.60
2025-09-26	CDXS	2.46	56.3	-	-0.60
2025-09-29	CDXS	2.47	56.3	-	-0.60
2025-09-30	CDXS	2.43	56.3	-	-0.60
2025-10-01	CDXS	2.50	56.3	-	-0.60
2025-10-02	CDXS	2.51	56.3	-	-0.60
2025-10-03	CDXS	2.54	56.3	-	-0.60
2025-10-06	CDXS	2.69	56.3	-	-0.60
2025-10-07	CDXS	2.55	56.3	-	-0.60
2025-10-08	CDXS	2.65	56.3	-	-0.60
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	CDXS	128.93	6.26	5.93
2025-09-09	CDXS	128.93	6.26	5.93
2025-09-10	CDXS	128.93	6.26	5.93
2025-09-11	CDXS	125.32	6.26	5.71
2025-09-12	CDXS	125.32	6.26	5.71
2025-09-15	CDXS	122.25	6.46	5.71
2025-09-16	CDXS	122.25	6.46	5.71
2025-09-17	CDXS	122.26	6.46	5.71
2025-09-18	CDXS	122.25	6.46	5.71
2025-09-19	CDXS	122.25	6.46	5.71
2025-09-22	CDXS	122.25	6.33	5.71
2025-09-23	CDXS	122.25	6.33	5.71
2025-09-24	CDXS	122.26	6.33	5.71
2025-09-25	CDXS	118.90	6.33	6.44
2025-09-26	CDXS	118.90	6.33	6.44
2025-09-29	CDXS	118.90	6.34	6.44
2025-09-30	CDXS	118.90	6.34	6.44
2025-10-01	CDXS	118.90	6.34	6.44
2025-10-02	CDXS	118.90	6.34	6.44
2025-10-03	CDXS	118.90	6.34	6.44
2025-10-06	CDXS	114.75	4.82	6.44
2025-10-07	CDXS	114.75	4.82	6.44
2025-10-08	CDXS	114.75	4.82	6.44
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

-0.13

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

114.75

Institutional Transactions

4.82

Beta

2.58

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

93.7

Max Drawdown 5-Year %

-96.4

Target Price

7.08

P/E

Forward P/E

PEG

P/S

4.18

P/B

4.29

P/Free Cash Flow

EPS

-0.82

Average EPS Est. Cur. Y

-0.6

EPS Next Y. (Est.)

-0.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-113.67

Relative Volume

0.33

Return on Equity vs Sector %

-142

Return on Equity vs Industry %

-128.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

Codexis, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 188

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

stock quote shares CDXS – Codexis, Inc. Stock Price stock today

news today CDXS – Codexis, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CDXS – Codexis, Inc. yahoo finance google finance

stock history CDXS – Codexis, Inc. invest stock market

stock prices CDXS premarket after hours

ticker CDXS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CDXS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y